Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trio-Tech International (TRT) Cash & Equivalents (2016 - 2025)

Trio-Tech International (TRT) has disclosed Cash & Equivalents for 16 consecutive years, with $12.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 20.16% to $12.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.4 million, a 20.16% increase, with the full-year FY2025 number at $10.9 million, up 8.52% from a year prior.
  • Cash & Equivalents was $12.4 million for Q4 2025 at Trio-Tech International, up from $12.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $12.4 million in Q4 2025 to a low of $5.2 million in Q3 2021.
  • A 5-year average of $8.8 million and a median of $8.7 million in 2023 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 82.25% in 2022; the steepest drop was 15.24% in 2022.
  • Trio-Tech International's Cash & Equivalents stood at $7.5 million in 2021, then dropped by 15.24% to $6.4 million in 2022, then skyrocketed by 71.91% to $11.0 million in 2023, then fell by 5.86% to $10.3 million in 2024, then rose by 20.16% to $12.4 million in 2025.
  • Per Business Quant, the three most recent readings for TRT's Cash & Equivalents are $12.4 million (Q4 2025), $12.3 million (Q3 2025), and $10.9 million (Q2 2025).